Daclizumab Subcutaneous and Lazanda
Determining the interaction of Daclizumab Subcutaneous and Lazanda and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: daclizumab
Brand name: Zinbryta, Zenapax
Synonyms: Daclizumab
Generic Name: fentanyl
Brand name: Lazanda, Abstral, Fentora, Subsys, Actiq, Duragesic, Ionsys, Onsolis, Sublimaze
Synonyms: Lazanda Nasal Spray
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Daclizumab Subcutaneous-Lazanda Nasal Spray
- Daclizumab Subcutaneous-Leader Acid Control
- Daclizumab Subcutaneous-Leader Acid Reducer Maximum Strength
- Daclizumab Subcutaneous-Leader All Day Allergy
- Daclizumab Subcutaneous-Leader Allergy D 12
- Daclizumab Subcutaneous-Leader Allergy Relief
- Lazanda-Dacogen
- Lazanda-Dacomitinib
- Lazanda-Dactinomycin
- Lazanda-Dactinomycin Injection
- Lazanda-Dactinomycin Intravenous
- Lazanda-Daklinza